What Is Hantavirus and Should Canadians Be Concerned?
Hantavirus is rare but serious. Here's what Canadians need to know about symptoms, how it spreads, and how to protect yourself.
Canada Just Approved a New Alzheimer’s Drug. Here’s What You Need to Know
Health Canada has approved a new Alzheimer's drug that targets the disease itself, not just symptoms. Here's what Canadians need to know.
Canada’s Doctors Are Sounding the Alarm on Health Misinformation And They’re Exhausted
97% of Canadian doctors have had to intervene after patients acted on false health information. The CMA says the crisis demands urgent action.
No More Needles: Canada Approves a Nasal Spray to Treat Severe Allergic Reactions
Health Canada approves neffy®, a needle-free epinephrine nasal spray for anaphylaxis. Learn how it works and when it’s coming to Canada.
Health Canada Warns: Think Twice Before Injecting Peptides Bought Online
Health Canada warns against unapproved peptide injections trending online for weight loss and anti-aging, citing serious health risks and lack of regulation.
Your Heart and Brain Are More Connected Than You Think
Canada's first brain-heart guideline calls on doctors to treat heart, brain, and mental health together. Here's what patients need to know.
Health Canada Approves Ozempic to Reduce Heart Attack and Stroke Risk
Health Canada expands Ozempic approval to include reducing the risk of heart attacks and strokes in adults with type 2 diabetes and heart or kidney disease.
Doctors Warn Canadians are “5x More Likely” to Experience Harm from AI Health Advice
A new report released today by the Canadian Medical Association (CMA) has revealed a dangerous new reality: Canadians…
Kidney Breakthrough: Health Canada Authorizes First-of-its-Kind Treatment for Lupus Nephritis
Health Canada authorizes Gazyva for lupus nephritis. Discover how this twice-yearly treatment improves kidney response and prevents failure.
Gen Z Health Crisis: Mental Health and Chronic Disease Claims Soar in Canada
A new Sun Life report reveals Gen Z health claims for mental health and chronic disease are rising 3x faster than any other generation in Canada.
Health Canada Authorizes Nemluvio® for Eczema and Prurigo Nodularis
Health Canada authorized Nemluvio® (nemolizumab), a first-in-class biologic for eczema and prurigo nodularis. Learn about costs and coverage.
Health Canada Authorizes First 8-Week Treatment for Acute Hepatitis C
Health Canada’s approval of MAVIRET for acute HCV allows doctors to treat adults and children immediately, a key step toward the 2030 elimination goal.